Otsuka America Pharmaceutical is categorized under Medical Research in Rockville, MD .
Otsuka America Pharmaceutical was established in 0, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Max Yoshitake at the company’s branch by writing to 9900 Medical Center Drive, Rockville, Maryland MD 20850 or by phoning (301) 424-9055. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Otsuka America Pharmaceutical |
| Contact Person: | Max Yoshitake |
| Address: | 9900 Medical Center Drive, Rockville, Maryland 20850 |
| Phone Number: | (301) 424-9055 |
| Website Address: | otsuka-us.com |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 4242101 |
| Share This Business: |
Otsuka America Pharmaceutical was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Max Yoshitake for inquiries that concern Otsuka America Pharmaceutical by calling the company number (301) 424-9055, as your correspondence is most welcome. Additionally, the physical location of the branch of Otsuka America Pharmaceutical can be found at the coordinates 39.098755,-77.202864 as well as the street address 9900 Medical Center Drive in Rockville, Maryland 20850.
For its online presence, you may visit Otsuka America Pharmaceutical’s website at otsuka-us.com and engage with its social media outlets through on Twitter and on Facebook.